I-Mab Biopharma
IMAB
#9317
Rank
โ‚น5.62 B
Marketcap
โ‚น69.07
Share price
-5.65%
Change (1 day)
-53.99%
Change (1 year)

Earnings for I-Mab Biopharma (IMAB)

Earnings in 2024 (TTM): -โ‚น16.66 Billion

According to I-Mab Biopharma's latest financial reports the company's current earnings are โ‚น3.27 Million. a decrease over its 2023 earnings that were of -โ‚น0.58 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for I-Mab Biopharma from 2017 to 2024

Annual earnings

Year Earnings Change
2024 -โ‚น4.28 Billion642.25%
2023 -โ‚น0.58 Billion-11.48%
2022-โ‚น0.66 Billion-86.72%
2021-โ‚น4.9 Billion-605.96%
2020 โ‚น0.96 B-138.32%
2019 -โ‚น2.53 Billion260.14%
2018 -โ‚น0.71 Billion19.49%
2017-โ‚น0.59 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-โ‚น1.55 Billion-90.90%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น0.89 Billion-94.81%๐Ÿ‡บ๐Ÿ‡ธ USA